U.S. Physical Therapy

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the following segments: physical therapy operations and industrial injury prevention services. The physical therapy operations segment consist of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The injury prevention services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. U.S. The company was founded in 1990 and is headquartered in Houston, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

U.S. Physical Therapy reports strong 2022 performance amidst industry challenges

U.S. Physical Therapy's strong performance in 2022 was marked by revenue growth, acquisitions, and improved operational efficiency, despite facing industry-specific challenges and headwinds.
The company's proactive approach to renegotiating contracts, implementing automation tools, and lobbying efforts positions it well to navigate potential risks and capitalize on growth opportunities.
While challenges like Medicare rate changes and economic uncertainties persist, the company's focus on strategic acquisitions, operational enhancements, and revenue optimization bode well for future performance.
With a cautious economic outlook, U.S. Physical Therapy remains resilient, leveraging its strengths in financial stability, operational efficiency, and proactive risk management to drive sustainable growth.

US Physical Therapy excels in Q1 2023, navigates challenges strategically

U.S. Physical Therapy (USPH) delivered strong Q1 2023 results, showcasing revenue growth, operational improvements, and strategic initiatives to enhance profitability.
While facing challenges from Medicare cuts and contract terminations, USPH's strengths in acquisitions, balance sheet, and operational efficiency position it well for future growth.
Opportunities in rate renegotiations, strategic realignment, and a customer-centric approach offer avenues for USPH to drive profitability and maintain competitive advantage.

U.S. Physical Therapy reports robust Q2 performance and growth strategies

USPH demonstrated strong performance in Q2 2023, with record patient demand and operational efficiency.
While facing challenges like staffing issues and contract delays, the company remains optimistic about future growth.
Renegotiating contracts and focusing on revenue enhancement are key strategies for driving profitability.
Overall, USPH's financial health and strategic initiatives position it well for sustained growth and success.

U.S. Physical Therapy reports robust Q3 growth and eyes acquisitions

Despite challenges in staffing and Medicare rate reductions, U.S. Physical Therapy's strong performance and strategic initiatives position it for growth. The company's focus on acquisitions, contract improvements, and service enhancements bode well for future success.

US Physical Therapy reports record growth and strategic acquisitions plan

USPH's Q4 2023 showcased strong revenue growth, margin improvement, and successful therapist recruitment despite challenges.
Strategic initiatives like payer contract renegotiation, group purchasing rollout, and focus on acquisitions position USPH for future growth.
Challenges include industry frustrations, CMS cuts, and the need to enhance workers' comp revenue trajectory.
Opportunities lie in same-store volume growth, increased focus on workers' comp, and M&A activities in the PT space.

U.S. Physical Therapy (USPH) exceeds Q1 expectations, eyes strategic growth

U.S. Physical Therapy (USPH) delivered a robust performance in Q1 2024, overcoming initial challenges to achieve revenue and profit growth.
With an upwardly revised EBITDA guidance, successful acquisitions, and a focus on strategic expansion, USPH is poised for continued success.
While facing challenges from Medicare rate reductions and adverse weather, USPH remains well-positioned with a strong financial foundation.
Optimism surrounds USPH's outlook, driven by organic growth strategies, potential M&A opportunities, and ongoing revenue enhancement efforts.

U.S. Physical Therapy reports strong Q2 performance amidst labor challenges

U.S. Physical Therapy's Q2 2024 performance showcased robust operational metrics and revenue growth, despite facing labor cost pressures. The company's strategic initiatives to address challenges and capitalize on opportunities position it for sustained success in the evolving healthcare landscape.

U.S. Physical Therapy reports robust Q3 performance and strategic realignment

USPH's Q3 2024 performance showcased revenue growth, operational improvements, and strategic realignment towards high-return markets.
While facing challenges with rising costs per visit, the company's focus on cost adjustments and growth opportunities positions it well for future success.
With a strong financial performance and strategic initiatives in place, USPH is poised for continued growth and profitability in the coming quarters.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The company was founded in 1990 and is headquartered in Houston, TX.

U.S. Physical Therapy's shares have tanked since the onset of the pandemic, falling 42% from $133 to $76.3 at the time of writing.

U.S. Physical Therapy Can Overcome Pandemic Pressures - A Strong Buy In My View

Shares of U.S. Physical Therapy Inc. USPH, +2.64% rallied 3.1% in morning trading Tuesday, after the operator of physical therapy clinics said about 300 furloughed employees have returned to work, as 10 of the clinics have reopened that the open clinics are now operating at about 70% of normal volumes.

U.S. Physical Therapy's stock rallies as some furloughed employees return, clinics reopen

U.S. Physical Therapy, Inc. (USPH) CEO Chris Reading on Q1 2020 Results - Earnings Call Transcript

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 50.00% and 9.95%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

U.S. Physical Therapy (USPH) Q1 Earnings and Revenues Surpass Estimates

Shares of US Physical Therapy (NYSE:USPH) rose 0.2% in pre-market trading after the company reported Q1 results.

US Physical Therapy: Q1 Earnings Insights

U.S. Physical Therapy, Inc. (USPH) CEO Chris Reading on Q4 2019 Results - Earnings Call Transcript

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of -5.88% and 0.74%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

U.S. Physical Therapy (USPH) Q4 Earnings Lag Estimates

Encompass Health

EHC vs. USPH: Which Stock Is the Better Value Option?

EHC or USPH: Which Is the Better Value Stock Right Now?

U.S. Physical Therapy, Inc. (USPH) CEO Chris Reading on Q3 2019 Results - Earnings Call Transcript

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 0.00% and -3.48%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

U.S. Physical Therapy (USPH) Q3 Earnings Match Estimates

CEO of Us Physical Therapy Inc (30-Year Financial, Insider Trades) Christopher J Reading (insider trades) sold 7,000 shares of USPH on 08/19/2019 at an average price of $135.13 a share.

Us Physical Therapy Inc (USPH) CEO Christopher J Reading Sold $945,910 of Shares

COO of Us Physical Therapy Inc (30-Year Financial, Insider Trades) Glenn Mcdowell (insider trades) sold 5,000 shares of USPH on 08/14/2019 at an average price of $134.55 a share.

Us Physical Therapy Inc (USPH) COO Glenn Mcdowell Sold $672,750 of Shares

U.S. Physical Therapy, Inc. (USPH) CEO Chris Reading on Q2 2019 Results - Earnings Call Transcript

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 0.00% and 1.17%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

U.S. Physical Therapy (USPH) Q2 Earnings Meet Estimates

Does U.S. Physical Therapy (USPH) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes U.S. Physical Therapy (USPH) a Strong Momentum Stock: Buy Now?

U.S. Physical Therapy, Inc. (USPH) CEO Christopher Reading on Q1 2019 Results - Earnings Call Transcript

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 6.45% and 0.46%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

News for U.S. Physical Therapy Stock (USPH)